Instructions for Favirox (famciclovir) film-coated tablets
English product name
Favirox
Release Form
tab. film sheath, 125 mg: 10 pcs
Description Favirox
The tablets are covered with a film shell of white color, round, double-convex.
1 tab.
famciclovir 125 mg
Auxiliary substances: pregelatinized starch - 18.7 mg, microcrystalline cellulose - 11 mg, sodium croskarmellose - 10.2 mg, sodium lauryl sulfate - 1.7 mg, silicon dioxide colloidal anhydrous - 1.7 mg, stearic acid - 1.7 mg.
Film coating: Opadray white OY-S-28924 (hypromellose-5sR - 1.87 mg, titanium dioxide - 1.02 mg, hypromellose-15sR - 0.62 mg, macrogol-4000 - 0.37 mg, macrogol-6000 - 0.37 mg) - 4.25 mg.
10 pcs. - blister packs (1) - cardboard packs.
ATC codes famciclovir
J05AB09 Famciclovir
Active substance
famciclovir
Pharmaco-therapeutic group Favirox
Antiviral agent
Pharmacological effect famciclovir
Antiviral drug. After ingestion, in vivo rapidly converts to pencyclovir, which has in vivo and in vitro activity against human herpes viruses, including Varicella zoster and Herpes simplex types 1 and 2, as well as Epstein-Barr and cytomegalovirus.
Testimony Favirox
Infections caused by the Varicella zoster virus (shingles, including shingles with eye complications); infections caused by the Herpes simplex virus (primary infection, exacerbation of chronic infection, suppression of recurrent infection).
Method of use, course and dosage Favirox
Treatment should begin immediately after diagnosis.
A single dose of 250-500 mg is taken orally. The frequency and duration of use depend on indications, immunity status, kidney function, treatment effectiveness.
- Nosology famciclovir (ICD codes)
- A60
- Anogenital herpetic virus infection [herpes simplex]
- B00
- Infections caused by herpes simplex virus [herpes simplex]
- B01
- Chickenpox [varicella]
- B02
- Shingles [herpes zoster]